Online

Clinical practice and implementation of image-guided stereotactic body radiotherapy 2021

Learn about the latest developments in stereotactic body radiotherapy and cranial stereotactic radiosurgery. Understand the physical and technical requirements and discuss ways to establish a multi-professional clinical stereotactic programme.

ESTRO is following closely the evolution of the COVID-19 pandemic to assess its impact on the courses scheduled for the second semester of 2021. After discussing with the course faculty, we convened that, given the uncertainty of the situation, it will not be possible to organise a live course in June 2021. Taking stock on the success of the online course that took place between 10 December 2020 and 9 February 2021, we decided to organise a second online course between November and December 2021. We are working with the faculty to develop a brand-new concept for an online course based on the positive experience of the last edition. We will be back with a full programme and an updated course webpage in May 2021.

 

If have already registered to the live course planned in June (now moved online to Nov-Dec 2021),  so you are entitled to a full refund of your registration fee. We have processed your refund on your credit card, you will be receiving it shortly.

 

Registrations to the online course will re-open in May.

Thank you for your patience and cooperation, we look forward to launching this new and improved edition of the course and we hope you will be joining us.

 

Course directors

  • Matthias Guckenberger, Radiation Oncologist, University Hospital Zurich, Zurich (CH)
  • Dirk Verellen, Medical Physicist, Iridium Kankernetwerk, University of Antwerp, Antwerp (BE)

Teachers

  • Karin Dieckmann, Radiation Oncologist, Medical University of Vienna, Vienna (AT)
  • Mischa S. Hoogeman, Medical Physicist, Erasmus Medical Centre-Daniel den Hoed Cancer Centre, Rotterdam (NL)
  • Coen Hurkmans, Medical Physicist, Catharina Hospital, Eindhoven (NL)
  • Stephanie Lang, Medical Physicist, University Hospital Zurich, Zurich (CH)
  • Piet Ost, Radiation Oncologist, Ghent University, Ghent (BE)
  • Suresh Senan, Radiation Oncologist, VU University Medical Centre, Amsterdam (NL)
  • Sophie Perryck, RTT, University Hospital Zurich, Zurich (CH)

This course aims to:

  • Inform about the historical background and development of cranial radiosurgery (SRS) and stereotactic- body radiotherapy (SBRT)
  • Illustrate the radiobiological consequences of hypo-fractionated, inhomogeneous dose distributions.
  • Discuss the practice of frame-less image-guided versus frame-based stereotactic cranial radiosurgery.
  • Identify potential sources of uncertainties in the work-flow of SBRT: imaging, target delineation, motion compensation, treatment planning, treatment delivery and treatment evaluation
  • Offer an overview of available treatment planning and delivery technologies and how to integrate these in clinical practice of SBRT •Compare available technologies and help define applicability for particular use
  • Give an evidence-based review on potential indications for SBRT: early stage NSCLC, primary and secondary liver metastases, prostate cancer, pancreatic cancer, vertebral metastases, oligometastases, re-irradiation
  • Give an overview of normal-tissue toxicity, tolerability and radiological changes in SBRT
  • Teach how to establish and implement a safe and clinical programme for SBRT.

Learning Outcomes

By the end of this course participants should be able to:

  • Build a team to implement and practice SRS, SRT and SBRT
  • Understand the technical and physical requirements for SRS, SRT and SBRT
  • Know the clinical rationale of SRS, SRT and SBRT and their limitations
  • Understand the radiobiological basis of very high fraction doses
  • Know the details of indication, practice and outcome of SBRT for early stage NSCLC
  • Know the current clinical evidence for SRS, SRT and SBRT in the various clinical indications.

Course Content

The five-day teaching course will be organised as follows:

  • On Sunday, a historical background of stereotactic radiotherapy will be given followed by the radiobiological and technological background; SBRT cases with different complexity will be demonstrated followed by a debate discussing the position of SBRT in the current developments in oncology
  • The teaching lectures on Monday will review and discuss the technology and physical practice of SBRT and SRS
  • On Tuesday, various clinical aspects will be discussed, and SBRT for early stage NSCLC, primary liver cancer, prostate cancer and pancreatic cancer will be reviewed
  • All teaching lectures will focus on the multi-disciplinary character of SBRT. Interaction and discussion between the professional groups is highly encouraged
  • Split-up sessions based on expertise in SBRT and based on the profession will be organised on Tuesday and Wednesday, offering the opportunity of in depth practical discussions
  • The last day will focus on the establishment of a clinical stereotactic programme and close with a panel discussion.

Prerequisites

Before commencing this course participant should:

  • Know the basics of image-guided radiotherapy
  • Have experience and knowledge of advanced radiotherapy treatment planning
  • Have a basic understanding of radiobiological modelling.

Teaching Methods

  • 20 hours of lectures
  • 4 hours of practical workshops
  • 1 hour of case discussions.

Methods of Assessment

  • MCQ
  • Evaluation form.

Venue

Crowne Plaza Brussels
Rue Gineste, 3
1210 Brussels
Belgium

Accommodation

Information to follow soon.

Programme

The scientific programme will be available soon.

Key Words

  • Stereotactic body radiotherapy
  • Radiosurgery
  • Stereotactic radiotherapy
  • image guided radiotherapy.

Accreditation

Application for CME and CDP recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS) and to the European Board for Accreditation in Medical Physics (EBAMP). EACCME and EBAMP credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

The course is aimed at all professionals in the field of radiation oncology, who are involved in the clinical practice of SBRT and cranial SRS at any point in the treatment chain: radiation oncologists, physicists and radiation therapists (RTTs) with a dedicated focus on SBRT and SRS. The course targets individuals who are currently at the planning stage of establishing a clinical stereotactic programme, and also those who already have a current stereotactic practice. The importance of integrating all professionals into a team will be highlighted.

This course is going online in November/December 2021

More information to follow in May.